Overview

An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065)

Status:
Terminated
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
This is a study to evaluate the effectiveness and tolerability of an investigational drug in patients with type 2 diabetes (a specific type of diabetes) who are not currently treated with insulin.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Collaborator:
Bristol-Myers Squibb